Identification of an immunodominant region on a group A Streptococcus T-antigen reveals temperature-dependent motion in pili

References

• Walker MJ, Barnett TC, McArthur JD, et al. Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clin Microbiol Rev. 2014;27:264–12.
   PubMed Web of Science ®Google Scholar
• Martin WJ, Steer AC, Smeesters PR, et al. Post-infectious group A streptococcal autoimmune syndromes and the heart. Autoimmun Rev. 2015;14:710–725.
   PubMed Web of Science ®Google Scholar
• Carapetis JR, Beaton A, Cunningham MW, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:1–24.
   Web of Science ®Google Scholar
• Bennett J, Zhang J, Leung W, et al. Incidence of acute rheumatic fever and rheumatic heart disease among ethnic groups, New Zealand, 2000–2018. Emerging Infect Dis. 2021;27. DOI:10.3201/eid2701.191791.
   Web of Science ®Google Scholar
• Wyber R, Noonan K, Halkon C, et al. Ending rheumatic heart disease in Australia: the evidence for a new approach. Med J Aust. 2020;213(Suppl 10):S3–31. DOI:10.5694/mja2.50853
   PubMedGoogle Scholar
• Brouwer S, Barnett TC, Hernandez TR, et al. Streptococcus pyogenes adhesion and colonization. FEBS Lett. 2016;590:3739–3757.
   PubMed Web of Science ®Google Scholar
• Raynes JM, Young PG, Proft T, et al. Protein adhesins as vaccine antigens for group A Streptococcus. Pathog Dis. 2018;76:1822.
   Web of Science ®Google Scholar
• Manetti AGO, Zingaretti C, Falugi F, et al. Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol Microbiol. 2007;64:968–983.
   PubMed Web of Science ®Google Scholar
• Becherelli M, Manetti AGO, Buccato S, et al. The ancillary protein 1 of Streptococcus pyogenes FCT-1 pili mediates cell adhesion and biofilm formation through heterophilic as well as homophilic interactions. Mol Microbiol. 2012;83:1035–1047.
   PubMed Web of Science ®Google Scholar
• Chen Y-H, Li S-H, Yang Y-C, et al. T4 pili promote colonization and immune evasion phenotypes of nonencapsulated M4 Streptococcus pyogenes. MBio. 2020;11. DOI:10.1128/mBio.01580-20.
   Web of Science ®Google Scholar
• Tsai J-YC, Loh JMS, Clow F, et al. The group A Streptococcus serotype M2 pilus plays a role in host cell adhesion and immune evasion. Mol Microbiol. 2016;103:282–298.
   PubMed Web of Science ®Google Scholar
• Mora M, Bensi G, Capo S, et al. Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens. Proc Natl Acad Sci, USA. 2005;102:15641–15646.
   PubMed Web of Science ®Google Scholar
• Nakata M, Kreikemeyer B. Genetics, structure, and function of group A streptococcal pili. Front Microbiol. 2021;12:616508.
   PubMed Web of Science ®Google Scholar
• Proft T, Baker EN. Pili in gram-negative and gram-positive bacteria - structure, assembly and their role in disease. Cell Mol Life Sci. 2009;66:613–635.
   PubMed Web of Science ®Google Scholar
• Kreikemeyer B, Nakata M, Oehmcke S, et al. Streptococcus pyogenes collagen type I-binding Cpa surface protein. Expression profile, binding characteristics, biological functions, and potential clinical impact. J Biol Chem. 2005;280:33228–33239.
   PubMed Web of Science ®Google Scholar
• Linke C, Young PG, Kang HJ, et al. Crystal structure of the minor pilin FctB reveals determinants of group A streptococcal pilus anchoring. J Biol Chem. 2010;285:20381–20389.
   PubMed Web of Science ®Google Scholar
• Köller T, Manetti AGO, Kreikemeyer B, et al. Typing of the pilus-protein-encoding FCT region and biofilm formation as novel parameters in epidemiological investigations of Streptococcus pyogenes isolates from various infection sites. J Med Microbiol. 2010;59:442–452.
   PubMed Web of Science ®Google Scholar
• Young PG, Raynes JM, Loh JM, et al. Group A Streptococcus T antigens have a highly conserved structure concealed under a heterogeneous surface that has implications for vaccine design. Infect Immun. 2019;87. DOI:10.1128/IAI.00205-19.
   Web of Science ®Google Scholar
• Bessen DE, Kalia A. Genomic localization of a T serotype locus to a recombinatorial zone encoding extracellular matrix-binding proteins in Streptococcus pyogenes. Infect Immun. 2002;70:1159–1167.
   PubMed Web of Science ®Google Scholar
• Young PG, Moreland NJ, Loh JM, et al. Structural conservation, variability, and immunogenicity of the T6 backbone pilin of serotype M6 Streptococcus pyogenes. Infect Immun. 2014;82:2949–2957.
   PubMed Web of Science ®Google Scholar
• Kang HJ, Coulibaly F, Clow F, et al. Stabilizing isopeptide bonds revealed in gram-positive bacterial pilus structure. Science. 2007;318:1625–1628.
   PubMed Web of Science ®Google Scholar
• Kang HJ, Baker EN. Intramolecular isopeptide bonds give thermodynamic and proteolytic stability to the major pilin protein of Streptococcus pyogenes. J Biol Chem. 2009;284:20729–20737.
   PubMed Web of Science ®Google Scholar
• Steer AC, Carapetis JR, Dale JB, et al. Status of research and development of vaccines for Streptococcus pyogenes. Vaccine. 2016;34:2953–2958.
   PubMed Web of Science ®Google Scholar
• Loh JMS, Lorenz N, Tsai CJY, et al. Mucosal vaccination with pili from group A Streptococcus expressed on Lactococcus lactis generates protective immune responses. Sci Rep. 2017;7:7174.
   PubMed Web of Science ®Google Scholar
• Falugi F, Zingaretti C, Pinto V, et al. Sequence variation in group A Streptococcus pili and association of pilus backbone types with Lancefield T serotypes. J Infect Dis. 2008;198:1834–1841.
   PubMed Web of Science ®Google Scholar
• Steemson JD, Moreland NJ, Williamson D, et al. Survey of the bp/tee genes from clinical group A streptococcus isolates in New Zealand – implications for vaccine development. J Med Microbiol. 2014;63:1670–1678.
   PubMed Web of Science ®Google Scholar
• Loh JMS, Rivera-Hernandez T, McGregor R, et al. A multivalent T-antigen-based vaccine for group A Streptococcus. Sci Rep. 2021;11:4353.
   PubMed Web of Science ®Google Scholar
• Raynes JM, Tay ML, By SH, et al. Isolation of Monoclonal Antibodies to group A Streptococcus Antigens using phage display. Methods Mol Biol. 2020;2136:255–268.
   PubMedGoogle Scholar
• Raynes JM, Frost HRC, Williamson DA, et al. Serological evidence of immune priming by group A Streptococci in patients with acute rheumatic fever. Front Microbiol. 2016;7:1119.
   PubMed Web of Science ®Google Scholar
• Barbas CF, Burton DR, Scott JK, et al. Phage display: a laboratory manual. Cold Spring Harbor Laboratory Press; 2001.
   Google Scholar
• Rader C. Generation and selection of rabbit antibody libraries by phage display. Methods Mol Biol 2009;525:101-28–xiv.
   PubMedGoogle Scholar
• Frost HR, Laho D, Sanderson-Smith ML, et al. Immune cross-opsonization within emm clusters following group A Streptococcus skin Infection: broadening the scope of type-specific immunity. Clin Infect Dis. 2017;65:1523–1531.
   PubMed Web of Science ®Google Scholar
• Newman J, Egan D, Walter TS, et al. Towards rationalization of crystallization screening for small- to medium-sized academic laboratories: the PACT/JCSG+ strategy. Acta Crystallogr Sect D Biological Crystallogr. 2005;61:1426–1431.
   PubMed Web of Science ®Google Scholar
• Gorrec F. The MORPHEUS protein crystallization screen. J Appl Crystallogr. 2009;42:1035–1042.
   PubMed Web of Science ®Google Scholar
• Kabsch W. Xds. Acta Crystallogr Sect D Biological Crystallogr. 2010;66:125–132.
   PubMed Web of Science ®Google Scholar
• Evans PR, Murshudov GN. How good are my data and what is the resolution? Acta Crystallogr Sect D Biological Crystallogr. 2013;69:1204–1214.
   PubMedGoogle Scholar
• McCoy AJ. Solving structures of protein complexes by molecular replacement with phaser. Acta Crystallogr Sect D. 2007;63:32–41.
   PubMedGoogle Scholar
• Emsley P, Lohkamp B, Scott WG, et al. Features and development of coot. Acta Crystallogr Sect D. 2010;66:486–501.
   PubMed Web of Science ®Google Scholar
• Murshudov GN, Skubák P, Lebedev AA, et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr Sect D Biological Crystallogr. 2011;67:355–367.
   PubMed Web of Science ®Google Scholar
• Moreland NJ, Tay MYF, Lim E, et al. Monoclonal antibodies against dengue NS2B and NS3 proteins for the study of protein interactions in the flaviviral replication complex. J Virol Methods. 2012;179:97–103.
   PubMed Web of Science ®Google Scholar
• Crombrugghe GD, Baroux N, Botteaux A, et al. The limitations of the rheumatogenic concept for group A Streptococcus: systematic review and genetic analysis. Clin Infect Dis. 2020;70:1453–1460.
   PubMed Web of Science ®Google Scholar
• Shea PR, Ewbank A, Gonzalez-Lugo J, et al. Group A Streptococcus emm Gene Types in Pharyngeal Isolates, Ontario, Canada, 2002–2010. Emerging Infect Dis. 2011;17:2010–2017.
   PubMed Web of Science ®Google Scholar
• Rudolph K, Bruce MG, Bruden D, et al. Epidemiology of invasive group A Streptococcal disease in Alaska, 2001 to 2013. J Clin Microbiol. 2016;54:134–141.
   PubMed Web of Science ®Google Scholar
• Williamson DA, Morgan J, Hope V, et al. Increasing incidence of invasive group A streptococcus disease in New Zealand, 2002–2012: a national population-based study. J Infect. 2015;70:127–134.
   PubMed Web of Science ®Google Scholar
• Plainvert C, Dinis M, Ravins M, et al. Molecular epidemiology of sil locus in clinical Streptococcus pyogenes strains. J Clin Microbiol. 2014;52:2003–2010.
   PubMed Web of Science ®Google Scholar
• Quigley BR, Hatkoff M, Thanassi DG, et al. A foreign protein incorporated on the tip of T3 pili in Lactococcus lactis elicits systemic and mucosal immunity. Infect Immun. 2010;78:1294–1303.
   PubMed Web of Science ®Google Scholar
• Lim X-X, Chandramohan A, Lim XYE, et al. Epitope and paratope mapping reveals temperature-dependent alterations in the dengue-antibody interface. Structure. 2017;25:1391–1402.e3.
   PubMed Web of Science ®Google Scholar
• Lok S-M, Kostyuchenko V, Nybakken GE, et al. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol. 2008;15:312–317.
   PubMed Web of Science ®Google Scholar
• Zhang S, Kostyuchenko VA, Ng T-S, et al. Neutralization mechanism of a highly potent antibody against Zika virus. Nat Commun. 2016;7:13679.
   PubMed Web of Science ®Google Scholar
• Pierson TC, Diamond MS. Degrees of maturity: the complex structure and biology of flaviviruses. Curr Opin Virol. 2012;2:168–175.
   PubMed Web of Science ®Google Scholar
• Pierson TC, Diamond MS. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev Mol Med. 2008;10:e12.
   PubMedGoogle Scholar